276 related articles for article (PubMed ID: 16581113)
21. Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.
Gennaro R; Barletta D; Paulis G
Int Urol Nephrol; 2015 Oct; 47(10):1595-602. PubMed ID: 26257044
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease.
Andresen R; Wegner HE; Banzer D; Miller K
Acta Radiol; 1996 May; 37(3 Pt 1):352-6. PubMed ID: 8845268
[TBL] [Abstract][Full Text] [Related]
24. Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.
Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Braun SE; Kim H; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
J Sex Med; 2015 Jul; 12(7):1533-44. PubMed ID: 26062100
[TBL] [Abstract][Full Text] [Related]
25. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.
Safarinejad MR; Hosseini SY; Kolahi AA
J Urol; 2007 Oct; 178(4 Pt 1):1398-403; discussion 1403. PubMed ID: 17706714
[TBL] [Abstract][Full Text] [Related]
26. The treatment of loss of penile rigidity associated with Peyronie's disease.
Krane RJ
Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
[TBL] [Abstract][Full Text] [Related]
27. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
28. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Cavallini G; Modenini F; Vitali G
Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
[TBL] [Abstract][Full Text] [Related]
29. A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the 'sliding' technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
Rolle L; Falcone M; Ceruti C; Timpano M; Sedigh O; Ralph DJ; Kuehhas F; Oderda M; Preto M; Sibona M; Gillo A; Garaffa G; Gontero P; Frea B
BJU Int; 2016 May; 117(5):814-20. PubMed ID: 26688436
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
[TBL] [Abstract][Full Text] [Related]
31. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.
Paulis G; Brancato T; D'Ascenzo R; De Giorgio G; Nupieri P; Orsolini G; Alvaro R
Andrology; 2013 Jan; 1(1):120-8. PubMed ID: 23258640
[TBL] [Abstract][Full Text] [Related]
33. Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review.
Choi EJ; Xu P; El-Khatib FM; Yafi FA
Sex Med Rev; 2021 Jul; 9(3):434-444. PubMed ID: 32660728
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease.
Prieto Castro RM; Leva Vallejo ME; Regueiro Lopez JC; Anglada Curado FJ; Alvarez Kindelan J; Requena Tapia MJ
BJU Int; 2003 Apr; 91(6):522-4. PubMed ID: 12656907
[TBL] [Abstract][Full Text] [Related]
35. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
Cavallini G; Biagiotti G; Koverech A; Vitali G
BJU Int; 2002 Jun; 89(9):895-900. PubMed ID: 12010235
[TBL] [Abstract][Full Text] [Related]
36. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Peyronie's disease with local interferon-alpha 2b.
Wegner HE; Andresen R; Knipsel HH; Miller K
Eur Urol; 1995; 28(3):236-40. PubMed ID: 8536778
[TBL] [Abstract][Full Text] [Related]
38. Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease.
Yafi FA; Hatzichristodoulou G; Knoedler CJ; Trost LW; Sikka SC; Hellstrom WJ
J Sex Med; 2015 Dec; 12(12):2492-8. PubMed ID: 26646187
[TBL] [Abstract][Full Text] [Related]
39. [Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
Lin HC; Zhang HT; Jiang H
Zhonghua Nan Ke Xue; 2017 Sep; 23(9):771-775. PubMed ID: 29726655
[TBL] [Abstract][Full Text] [Related]
40. Experience with intraplaque injection of verapamil for Peyronie's disease.
Levine LA; Goldman KE; Greenfield JM
J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
